Shares of Medtronic (MDT) gained 1.4% after the company received approval from the U.S. Food and Drug Administration for Vanta, a recharge-free implantable neurostimulator. The neurostimulator offers personalized pain relief, broad MRI compatibility, and almost double the device life in certain settings. It also uses MDT’s AdaptiveStim technology for customized pain relief that adjusts to the patient's body position using a built-in accelerometer. (See MDT stock analysis on TipRanks) VP and GM of Pain Therapies at Medtronic, Charlie Covert, said, “We are committed to delivering innovative solutions that meet the needs of every patient. Vanta neurostimulator offers the best hardware and features available today.
https://www.tipranks.com/news/medtronic-receives-fda-approval-for-neurostimulator-shares-rise-1-4
Medtronic (NYSE:MDT)
Historical Stock Chart
From Jun 2021 to Jul 2021 Click Here for more Medtronic Charts.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Jul 2020 to Jul 2021 Click Here for more Medtronic Charts.